CeQur Closes $27M Series B Financing
Summary
CeQur SA, a Horw, Switzerland-based company focused on the development and commercialization of simple insulin delivery devices, closed a $27m Series B financing.The round was led by two new private investors with participation of all current shareholders.The company intends to use the funds to manufacture the CeQur PaQ® simple insulin delivery device, which received CE Mark approval in November 2012, as well as to fund activities related to United States regulatory approval.Established in January 2008 and led by CEO James Peterson, CeQur develops and commercializes advanced insulin delivery devices for people living with type 2 diabetes to adhere to therapy and stay in control of their disease.The company also has operations in Nordborg, Denmark and Marlborough, Massachusetts.
Funding
Review available funding amount, funding date, investors, and linked company information related to CeQur Closes $27M Series B Financing in the interactive ISVWorld profile.